Pulmonary arterial hypertension in primary amyloidosis

Meghan M. Cirulis, Lyska L. Emerson, David A. Bull, Nathan Hatton, Jose Nativi-Nicolai, Gerhard C. Hildebrandt, John J. Ryan

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Amyloidosis involves extravascular deposition of fibrillar proteins within tissues and organs. Primary light chain amyloidosis represents the most common form of systemic amyloidosis involving deposition of monoclonal immunoglobulin light chains. Although pulmonary amyloid deposition is common in primary amyloidosis, clinically significant pulmonary amyloidosis is uncommon, and elevated pulmonary artery pressures are rarely observed in the absence of other underlying etiologies for pulmonary hypertension, such as elevated filling pressures secondary to cardiac amyloid. In this case report, we present a patient with primary light chain amyloidosis and pulmonary arterial hypertension in the setting of pulmonary vascular and right ventricular myocardial amyloid deposition.

Original languageEnglish
Pages (from-to)244-248
Number of pages5
JournalPulmonary Circulation
Issue number2
StatePublished - Jun 2016

Bibliographical note

Publisher Copyright:
© 2016 by the Pulmonary Vascular Research Institute. All rights reserved.


  • Congo red stain
  • Medial hypertrophy
  • Multiple myeloma
  • Pulmonary vascular disease

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Pulmonary arterial hypertension in primary amyloidosis'. Together they form a unique fingerprint.

Cite this